33
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Créer
Close
Create a timeline
Public timelines
Library
FAQ
Éditer
Télécharger
Export
Créer une copie
Premium
Intégrer dans le site Web
Share
End dates of pivitol studies
Category:
Autre
mise à jour avec succès:
5 nov. 2018
0
0
355
Auteurs
Created by
letrishka
Attachments
Comments
Payload timeline
By
letrishka
3 sept. 2018
0
0
470
Les événements
Anetumab ravtansine Mesothelioma
Mirvetuximab soravtansine
Polatuzumab vedotin Diffues large B-cell lymphoma
Enfortumab vedotin Urothelial bladder cancer
Trastuzumab duocarmazine HER-2+ve breast cancer
Trastuzumab deruxtecan Breast cancer
Depatuxizumab mafodotin Glioblastoma
Mirvetuximab soravtansine Ovarian cancer (PROC)
Sacituzumab govitecan Triple negative breast cancer (TBNC)
Rova-T (TRINITY) Small cell lung cancer
About & Feedback
Un accord
Confidentialité
Bibliothèque
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments